TTY Biopharm Co (ROCO:4105) Days Payable : 23.56 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is TTY Biopharm Co Days Payable?

TTY Biopharm Co's average Accounts Payable for the three months ended in Dec. 2023 was NT$199 Mil. TTY Biopharm Co's Cost of Goods Sold for the three months ended in Dec. 2023 was NT$770 Mil. Hence, TTY Biopharm Co's Days Payable for the three months ended in Dec. 2023 was 23.56.

The historical rank and industry rank for TTY Biopharm Co's Days Payable or its related term are showing as below:

ROCO:4105' s Days Payable Range Over the Past 10 Years
Min: 23.3 Med: 36.86 Max: 53.51
Current: 35.08

During the past 13 years, TTY Biopharm Co's highest Days Payable was 53.51. The lowest was 23.30. And the median was 36.86.

ROCO:4105's Days Payable is ranked worse than
86.8% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.3 vs ROCO:4105: 35.08

TTY Biopharm Co's Days Payable declined from Dec. 2022 (46.77) to Dec. 2023 (23.56). It may suggest that TTY Biopharm Co accelerated paying its suppliers.

TTY Biopharm Co Days Payable Historical Data

The historical data trend for TTY Biopharm Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TTY Biopharm Co Days Payable Chart

TTY Biopharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

40.83

37.63

29.28

31.89

38.25

TTY Biopharm Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															46.77	45.46	40.17	34.70	23.56

Competitive Comparison of TTY Biopharm Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, TTY Biopharm Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TTY Biopharm Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTY Biopharm Co's Days Payable distribution charts can be found below:

* The bar in red indicates where TTY Biopharm Co's Days Payable falls into.

TTY Biopharm Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

TTY Biopharm Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (226.418	+	238.53)	/	2 )	/	2218.466	*	365
=	232.474					/	2218.466	*	365
=	38.25

TTY Biopharm Co's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (158.956	+	238.53)	/	2 )	/	769.877	*	365 / 4
=	198.743					/	769.877	*	365 / 4
=	23.56

TTY Biopharm Co Days Payable Related Terms

Thank you for viewing the detailed overview of TTY Biopharm Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

TTY Biopharm Co (ROCO:4105) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTY Biopharm Co Ltd (ROCO:4105) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503

Website

https://www.tty.com.tw

TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segment includes Oncology, Health Care, Anti-Infection, Domestic Cardiovascular and Gastrointestinal Drugs, and other segments. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in European and Other Countries. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.

TTY Biopharm Co (ROCO:4105) Headlines

No Headlines